Unleashing the Therapeutic Power of Natural Alkaloids in Triple-Negative Breast Cancer: State-of-the-Art Advances and...

Area of Science:

• Oncology
• Pharmacology
• Natural Products Chemistry

Background:

• Triple-negative breast cancer (TNBC) is aggressive, lacking ER, PR, and HER2 receptors.
• TNBC's heterogeneity and limited treatment options pose significant clinical challenges.
• Naturally derived alkaloids are emerging as potential therapeutic agents for TNBC.

Purpose of the Study:

• To review advancements in alkaloid-based therapies for TNBC over the last decade.
• To analyze the impact of alkaloids on critical signaling pathways in TNBC.
• To discuss challenges and future directions for clinical translation of alkaloid therapies.

Main Methods:

• Comprehensive literature review of studies on natural alkaloids and TNBC.
• Analysis of signaling pathways targeted by alkaloids, including PI3K/AKT/mTOR, STAT3, TGF-β, NF-κB, and p38 MAPK.
• Evaluation of clinical translation challenges and future research directions.

Main Results:

• Alkaloids demonstrate efficacy in targeting key TNBC signaling pathways.
• Natural alkaloids offer potential for innovative and personalized therapeutic strategies.
• Challenges such as poor bioavailability and toxicity require further investigation.

Conclusions:

• Natural alkaloids hold significant promise for developing novel TNBC treatments.
• Targeting specific signaling pathways with alkaloids could lead to improved patient outcomes.
• Further high-quality research is crucial to establish the clinical efficacy of alkaloid-based therapies for TNBC.